Home › Free Stock Grades › AVLN
Avalyn Pharma Inc. Common Stock (AVLN) Stock Grade
AVLN · Healthcare
A+
Market Cap
$1.2B
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
35.7%
Dividend Yield
None
About Avalyn Pharma Inc. Common Stock's fundamentals
Avalyn Pharma is a $1.2 billion market cap pharmaceutical company with flat year-over-year revenue growth of 0.0% and a net margin of 0.0%, reflecting recent losses reported in its latest annual statement. Despite the unprofitable position, the company shows a return on equity of 35.7%, indicating efficient use of shareholder capital relative to earnings. The company does not currently pay a dividend and lacks a meaningful P/E ratio given its loss-making status.